{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:39:34Z","timestamp":1785159574062,"version":"3.55.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1210\/jc.2016-3931","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T15:10:45Z","timestamp":1492614645000},"page":"1712-1718","source":"Crossref","is-referenced-by-count":23,"title":["Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals"],"prefix":"10.1210","volume":"102","author":[{"given":"Sandrine Andrea","family":"Urwyler","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, CH-4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, CH-4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schuetz","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University Hospital Basel, CH-4031 Basel, Switzerland"},{"name":"Department of Endocrinology, Medical University Clinic, Kantonsspital Aarau, CH-5001 Aarau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahim","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, CH-4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, CH-4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Y.","family":"Donath","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, CH-4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, CH-4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, CH-4031 Basel, Switzerland"},{"name":"Department of Clinical Research, University Hospital Basel, CH-4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"issue":"17","key":"2019041122262338500_B1","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1001\/jama.298.17.2028","article-title":"Cause-specific excess deaths associated with underweight, overweight, and obesity","volume":"298","author":"Flegal","year":"2007","journal-title":"JAMA"},{"key":"2019041122262338500_B2","unstructured":"World Health Organization. Fact sheet No 311, obesity and overweight (online). http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/.Accessed 21 February 2017."},{"issue":"1","key":"2019041122262338500_B3","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1002\/oby.20083","article-title":"Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature","volume":"21","author":"Abraham","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"2019041122262338500_B4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/jcem-24-9-832","article-title":"Cortisol metabolism in obesity","volume":"24","author":"Dunkelman","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"3-5","key":"2019041122262338500_B5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jsbmb.2010.01.008","article-title":"Brief review: glucocorticoid excretion in obesity","volume":"121","author":"M\u00fcssig","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122262338500_B6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1196\/annals.1367.009","article-title":"The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome","volume":"1083","author":"Pasquali","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"2019041122262338500_B7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0026-0495(92)90171-6","article-title":"Cortisol secretion in relation to body fat distribution in obese premenopausal women","volume":"41","author":"M\u00e5rin","year":"1992","journal-title":"Metabolism"},{"issue":"8","key":"2019041122262338500_B8","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","article-title":"Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis","volume":"94","author":"Anagnostis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041122262338500_B9","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jc.2013-4398","article-title":"Relationships between 24-hour urinary free cortisol concentrations and metabolic syndrome in obese children","volume":"99","author":"Reinehr","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041122262338500_B10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1099800415604437","article-title":"Salivary biomarkers of chronic psychosocial stress and CVD risks: a systematic review","volume":"18","author":"An","year":"2016","journal-title":"Biol Res Nurs"},{"issue":"5","key":"2019041122262338500_B11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1210\/jc.2012-3663","article-title":"High long-term cortisol levels, measured in scalp hair, are associated with a history of cardiovascular disease","volume":"98","author":"Manenschijn","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122262338500_B12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122262338500_B13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2019041122262338500_B14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cmet.2013.05.001","article-title":"Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity","volume":"17","author":"Donath","year":"2013","journal-title":"Cell Metab"},{"issue":"2","key":"2019041122262338500_B15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cyto.2015.05.005","article-title":"IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance","volume":"75","author":"Ballak","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"2019041122262338500_B16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.phrs.2006.11.002","article-title":"Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels","volume":"55","author":"Di Renzo","year":"2007","journal-title":"Pharmacol Res"},{"issue":"3","key":"2019041122262338500_B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nutres.2013.01.005","article-title":"Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification","volume":"33","author":"Chae","year":"2013","journal-title":"Nutr Res"},{"issue":"5","key":"2019041122262338500_B18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1381\/096089204323093345","article-title":"The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss","volume":"14","author":"Cottam","year":"2004","journal-title":"Obes Surg"},{"issue":"2","key":"2019041122262338500_B19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3945\/ajcn.111.013771","article-title":"Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction","volume":"94","author":"Dalmas","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2019041122262338500_B20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"2019041122262338500_B21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2000.tb05368.x","article-title":"The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection","volume":"917","author":"McCann","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2019041122262338500_B22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03349862","article-title":"Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1 beta, TNF alpha and IL-6: a dose response study","volume":"19","author":"van der Meer","year":"1996","journal-title":"J Endocrinol Invest"},{"issue":"4729","key":"2019041122262338500_B23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1126\/science.2997929","article-title":"Corticotropin-releasing activity of monokines","volume":"230","author":"Woloski","year":"1985","journal-title":"Science"},{"issue":"6","key":"2019041122262338500_B24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000126796","article-title":"Endothelin-1 stimulates the in vitro release of neurohypophyseal hormones, but not corticotropin-releasing hormone, via ETA receptors","volume":"60","author":"Yasin","year":"1994","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2019041122262338500_B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yfrne.2008.10.001","article-title":"Interleukin-1 (IL-1): a central regulator of stress responses","volume":"30","author":"Goshen","year":"2009","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"2019041122262338500_B26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/endo-128-1-37","article-title":"Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway","volume":"128","author":"Navarra","year":"1991","journal-title":"Endocrinology"},{"issue":"1","key":"2019041122262338500_B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action","volume":"79","author":"Turnbull","year":"1999","journal-title":"Physiol Rev"},{"issue":"4826","key":"2019041122262338500_B28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.2821620","article-title":"Release of multiple hormones by a direct action of interleukin-1 on pituitary cells","volume":"238","author":"Bernton","year":"1987","journal-title":"Science"},{"issue":"1","key":"2019041122262338500_B29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-neuro-endocrine interactions: facts and hypotheses","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041122262338500_B30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood.V78.6.1420.1420","article-title":"A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer","volume":"78","author":"Crown","year":"1991","journal-title":"Blood"},{"key":"2019041122262338500_B31"},{"issue":"7","key":"2019041122262338500_B32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"15","key":"2019041122262338500_B33","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041122262338500_B34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"issue":"2","key":"2019041122262338500_B35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cmet.2015.11.013","article-title":"Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 co-transporter in the nephron","volume":"23","author":"Zhang","year":"2016","journal-title":"Cell Metab"},{"issue":"1","key":"2019041122262338500_B36","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041122262338500_B37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1043-4666(05)80001-8","article-title":"Cytokines and hypothalamic-pituitary function","volume":"5","author":"Jones","year":"1993","journal-title":"Cytokine"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/5\/1712\/16630141\/jc.2016-3931.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T21:45:21Z","timestamp":1601934321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/5\/1712\/3038071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,2,20]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3931","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,2,20]]}}}